Journal article
Koalas first: lessons from a wildlife Chlamydia vaccine
Trends in Microbiology, Vol.Advanced access
23-Mar-2026
PMID: 41876294
Abstract
Koalas are the first wildlife species with a conditionally approved Chlamydia pecorum vaccine, offering a natural-host system for a pathogen whose human counterpart, Chlamydia trachomatis, lacks a licensed vaccine. Human vaccine efforts are slowed by uncertain immune correlates, asymptomatic infection, licensure-relevant disease end points, strict regulatory requirements, and limited commercial incentives, with only one candidate completing Phase 1. Koalas share these constraints, but visible ocular and urogenital disease enables clinical assessment under natural infection. Koala vaccine design integrated dominant circulating C. pecorum genotypes with a single-dose Tri-Adjuvant, evaluated for safety, immunogenicity, and clinical outcomes. Conditional approval under Australia’s veterinary minor-use pathway relied on real-world evidence rather than controlled challenge studies. This opinion article highlights how natural-host evidence frameworks can inform intracellular pathogen vaccinology.
Details
- Title
- Koalas first: lessons from a wildlife Chlamydia vaccine
- Authors
- Nina M. Pollak (Corresponding Author) - University of the Sunshine CoastSamuel Phillips - University of the Sunshine CoastPeter Timms - University of the Sunshine Coast
- Publication details
- Trends in Microbiology, Vol.Advanced access
- Publisher
- Cell Press
- DOI
- 10.1016/j.tim.2026.02.003
- ISSN
- 1878-4380
- PMID
- 41876294
- Copyright note
- © 2026 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- Organisation Unit
- School of Health - Biomedicine; Centre for Bioinnovation
- Language
- English
- Record Identifier
- 991219492302621
- Output Type
- Journal article
Metrics
1 File views/ downloads
1 Record Views